Financials

  • Market Capitalization 222.4 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.86
Rapporto prezzo/fatturato
-167.18

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3554
CHRS
Coherus Oncology, Inc. - Common Stock
1.46 USD+0.69%+10.61%+1.39%-9.32%225.57 M USD
3564
KROS
Keros Therapeutics, Inc. - common stock
11.23 USD+0.99%+2.46%+10.75%-25.63%222.66 M USD
3572
ABOS
Acumen Pharmaceuticals, Inc. - Common Stock
3.03 USD+1.34%-5.61%+32.31%+124.44%219.12 M USD
3573
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.33 USD-0.69%+0.93%+10.18%-39.36%218.90 M USD

Notizie